Literature DB >> 2808321

Structural analysis of choline phospholipids by fast atom bombardment mass spectrometry and tandem mass spectrometry.

A Hayashi1, T Matsubara, M Morita, T Kinoshita, T Nakamura.   

Abstract

The structures of intact choline phospholipids were determined by positive and negative ion mode fast atom bombardment mass spectrometry, tandem mass spectrometry, and B2/E and B/E constant linked scan mass spectrometry. The molecular weight of the choline lipid could be clearly determined by the appearance of [M + H]+ or [M + Na]+ in the positive ion mode and triplet ions, e.g., [M - 15]-, [M - 60]-, and [M - 86]-, in the negative ion mode. The structures of the triplet ions were assigned to [M - CH3]-, [M - HN(CH3)3]-, and [M - CH2 = CHN(CH3)3]-, respectively, by the MS/MS of each triplet ion, and the origin of the triplet ions was found as the matrix-ion adduct to the target molecule by using the B2/E linked scan technique. The polar group could be identified by the existence of ions indicating glycerophosphocholine and its cleavage products and by the presence of the triplet ions in the negative ion mode. Positional determination of the distribution of constituent fatty acyl groups was carried out by comparing the intensity of deacylated ions from positions 1 and 2 in the positive ion mode and of the ions produced by MS/MS of the triplet ions. From the mass number of the [RCOO]- ion which appeared in the negative ion mode, the molecular weight and degree of unsaturation of the fatty acyl group were determined. The position of double bond(s) in the acyl group was determined from the MS/MS of the [RCOO]- ion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808321     DOI: 10.1093/oxfordjournals.jbchem.a122842

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids.

Authors:  Elena Vladykovskaya; Evgeny Ozhegov; J David Hoetker; Zhengzhi Xie; Yonis Ahmed; Jill Suttles; Sanjay Srivastava; Aruni Bhatnagar; Oleg A Barski
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

Review 2.  Sphingolipidomics: methods for the comprehensive analysis of sphingolipids.

Authors:  Christopher A Haynes; Jeremy C Allegood; Hyejung Park; M Cameron Sullards
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-12-31       Impact factor: 3.205

Review 3.  Analysis of mammalian sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS).

Authors:  M Cameron Sullards; Ying Liu; Yanfeng Chen; Alfred H Merrill
Journal:  Biochim Biophys Acta       Date:  2011-07-01

4.  Rhizobium meliloti mutants deficient in phospholipid N-methyltransferase still contain phosphatidylcholine.

Authors:  K E de Rudder; J E Thomas-Oates; O Geiger
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

5.  Cloning and characterization of the phosphatidylserine synthase gene of Agrobacterium sp. strain ATCC 31749 and effect of its inactivation on production of high-molecular-mass (1-->3)-beta-D-glucan (curdlan).

Authors:  Tara Karnezis; Helen C Fisher; Gregory M Neumann; Bruce A Stone; Vilma A Stanisich
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

6.  Characterization of Diacylglycerylphosphocholine Molecular Species by FAB-CAD-MS/MS: A General Method Not Sensitive to the Nature of the Fatty Acyl Groups.

Authors:  Z H Huang; D A Gage; C C Sweeley
Journal:  J Am Soc Mass Spectrom       Date:  1992-01       Impact factor: 3.109

7.  Fast atom bombardment tandem mass spectrometry employing ion-molecule reactions for the differentiation of phospholipid classes.

Authors:  M J Cole; C G Enke
Journal:  J Am Soc Mass Spectrom       Date:  1991-12       Impact factor: 3.109

8.  Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.

Authors:  T E Bapiro; K K Frese; A Courtin; J L Bramhall; B Madhu; N Cook; A Neesse; J R Griffiths; D A Tuveson; D I Jodrell; F M Richards
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.